

Instance: auth-for-45f0935e8c6afee1cac2e42562b88f23
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/575"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-45f0935e8c6afee1cac2e42562b88f23)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-79d94ef7008f11d676a4adb2f00ebf9c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, losartaan"
Description: "Regulated Authorization for amlodipiin, losartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837914"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-79d94ef7008f11d676a4adb2f00ebf9c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-0a031421e9bcacd66a18c1675483f31f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, atorvastatiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, atorvastatiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885515"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0a031421e9bcacd66a18c1675483f31f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-f882e68544af7ff49caa3b421488962b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "835014"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f882e68544af7ff49caa3b421488962b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-adcabea100f781d707218f571c4f037f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, amlodipiin"
Description: "Regulated Authorization for indapamiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "825213"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-adcabea100f781d707218f571c4f037f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-17e91c9786af1c33ef3711746fdd699f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/372"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-17e91c9786af1c33ef3711746fdd699f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-c647a5eaa7f88cc677cc523cd4489f33
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/569"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c647a5eaa7f88cc677cc523cd4489f33)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-10-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-35d09173235f772753a77e53a9ea7cf5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/569"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-35d09173235f772753a77e53a9ea7cf5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-10-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-92d33ee71b4da091e8b7e9f612b8e1ff
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, valsartaan"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/575"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-92d33ee71b4da091e8b7e9f612b8e1ff)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-f731a02dc6726c193e888eb8473bce7c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, telmisartaan"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/10/648"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f731a02dc6726c193e888eb8473bce7c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2010-10-07"
* holder = Reference(ORG-100012432)

Instance: auth-for-cbb5b7c3355aa4ad4452daa5ccf361d8
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "808113"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cbb5b7c3355aa4ad4452daa5ccf361d8)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-03-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-35853d394af67d440318431128545504
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "744511"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-35853d394af67d440318431128545504)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-06-10"
* holder = Reference(MO193)

Instance: auth-for-5247de08b58896d4604494db80171dbb
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023521"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5247de08b58896d4604494db80171dbb)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-b7b1332419d9664bd0a99267c5ca5d15
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/575"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b7b1332419d9664bd0a99267c5ca5d15)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-c3588d5de2aa94d14dfc321e47b53873
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "176397"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c3588d5de2aa94d14dfc321e47b53873)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "1997-08-22"
* holder = Reference(ORG-100023206)

Instance: auth-for-a1678839878d289a5d59bc56a5c851c3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730111"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a1678839878d289a5d59bc56a5c851c3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-9bc7efd141bacc1f239a88bf248c4a49
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017220"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9bc7efd141bacc1f239a88bf248c4a49)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-01-06"
* holder = Reference(ORG-100010645)

Instance: auth-for-16567a37a49722b6efb051ab302e0806
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "979619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-16567a37a49722b6efb051ab302e0806)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-02-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-751982d36267f6af45f89450a66228d5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1008020"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-751982d36267f6af45f89450a66228d5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-8bd0ba4c333aa18d77bf0705a8ced0ba
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730411"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8bd0ba4c333aa18d77bf0705a8ced0ba)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-7fcb407288ad62b918b13e365fbd54cc
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982419"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7fcb407288ad62b918b13e365fbd54cc)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-110a0c04656125cfacee1f7d25d7b2a4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "606308"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-110a0c04656125cfacee1f7d25d7b2a4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-10-31"
* holder = Reference(ORG-100001429)

Instance: auth-for-8824260f5cc166a9c5c9fcebf6d2daad
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "949617"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8824260f5cc166a9c5c9fcebf6d2daad)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-09-12"
* holder = Reference(ORG-100000627)

Instance: auth-for-03965de418b25ef6cb5db065291a7f06
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1008120"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-03965de418b25ef6cb5db065291a7f06)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-018b2aca0bd97853048671b255066e99
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-018b2aca0bd97853048671b255066e99)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-fb0b7baa5d9eda64115a890415e80475
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730211"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-fb0b7baa5d9eda64115a890415e80475)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-1eb740d7e18811fcb9c04e22b23627d2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/371"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1eb740d7e18811fcb9c04e22b23627d2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-48e9dc9be347304877f019cdb587cb6f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/574"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-48e9dc9be347304877f019cdb587cb6f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-4b80c9797bfb38a9ee6bdb59d74bd7b1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040721"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4b80c9797bfb38a9ee6bdb59d74bd7b1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-7d8038aee37a8ee6fbbba9733a63ad82
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730511"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7d8038aee37a8ee6fbbba9733a63ad82)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-988b0afba39c079462ec0e0709b0b508
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040521"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-988b0afba39c079462ec0e0709b0b508)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-a2bef397893b54b8eae7940bb907c558
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838614"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a2bef397893b54b8eae7940bb907c558)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-092b46c08330d1ca1bae308f5e4b937b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "567207"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-092b46c08330d1ca1bae308f5e4b937b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-12-14"
* holder = Reference(MO11501)

Instance: auth-for-16642694776ad41637e51f838bf36e59
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Description: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-16642694776ad41637e51f838bf36e59)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-57321416664c7aa448e26e4435b8d832
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "954517"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-57321416664c7aa448e26e4435b8d832)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-11-07"
* holder = Reference(ORG-100004108)

Instance: auth-for-de308c5750783b4c65d5394796ab1031
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for kandesartaan, amlodipiin"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915916"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-de308c5750783b4c65d5394796ab1031)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-ad2c494913abfd1d3251a1d63c46d80b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007720"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ad2c494913abfd1d3251a1d63c46d80b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-2f5b81f0974784e0d5e5a493bb64b687
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, losartaan"
Description: "Regulated Authorization for amlodipiin, losartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2f5b81f0974784e0d5e5a493bb64b687)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-7163d35a4bbf42862b1a21653e2a3fb8
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid"
Description: "Regulated Authorization for amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "825313"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7163d35a4bbf42862b1a21653e2a3fb8)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-199f1c0c9ac4de4f24f1558dd5a3ab3b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, atorvastatiin, amlodipiin"
Description: "Regulated Authorization for perindopriil, atorvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885115"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-199f1c0c9ac4de4f24f1558dd5a3ab3b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-120a9fe8ffb97fba32388a9003b0acd6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "835714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-120a9fe8ffb97fba32388a9003b0acd6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-daf7a27e4f2cefda4f055fdac2f30736
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for kandesartaan, amlodipiin"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "847914"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-daf7a27e4f2cefda4f055fdac2f30736)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-06-27"
* holder = Reference(ORG-100004108)

Instance: auth-for-37f8128853136f233f44e712f4619741
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "589208"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-37f8128853136f233f44e712f4619741)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-06-20"
* holder = Reference(ORG-100000229)

Instance: auth-for-eff1a621eaa44e230dbc8202935fa9f9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid"
Description: "Regulated Authorization for amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "824413"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-eff1a621eaa44e230dbc8202935fa9f9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-c6be6843aaa3cbf4327d96a2295712ce
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, rosuvastatiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, rosuvastatiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c6be6843aaa3cbf4327d96a2295712ce)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-a99e9ee77f8a50d0042744aa6c1a3d7b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023821"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a99e9ee77f8a50d0042744aa6c1a3d7b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-adc445ece170145f48fdc5e25c29934c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838414"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-adc445ece170145f48fdc5e25c29934c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-40ddf0f34f98046f27a2be3a5b39afe7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "418403"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-40ddf0f34f98046f27a2be3a5b39afe7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2003-08-08"
* holder = Reference(ORG-100004108)

Instance: auth-for-b5a26b3c5e3c9ecab032122846a7ef5e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "882315"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b5a26b3c5e3c9ecab032122846a7ef5e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100004108)

Instance: auth-for-5a003a4d377b6cb57262a8f7c0d376f1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil, indapamiid"
Description: "Regulated Authorization for amlodipiin, perindopriil, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040821"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5a003a4d377b6cb57262a8f7c0d376f1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-bf040138a13adaa280a2271e87c6f253
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Description: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996819"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-bf040138a13adaa280a2271e87c6f253)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-9074e4ce1245d96020e62afdb2505327
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, ramipriil"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9074e4ce1245d96020e62afdb2505327)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:53
* holder = Reference(ORG-100002040)

Instance: auth-for-446c3f0a7c1b513b021f1df2fadfee3c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-446c3f0a7c1b513b021f1df2fadfee3c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-4c9bfeb261f0bb3bde9569d02f5b9452
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982819"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4c9bfeb261f0bb3bde9569d02f5b9452)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-25271f42d1512b756038bd83377006e2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "835314"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-25271f42d1512b756038bd83377006e2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-ea24a3ba02de5b428a814ead61a56403
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil, atorvastatiin"
Description: "Regulated Authorization for amlodipiin, perindopriil, atorvastatiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885215"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ea24a3ba02de5b428a814ead61a56403)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-507e037e7b53f108597aa8104023b0ee
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "418303"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-507e037e7b53f108597aa8104023b0ee)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2003-08-08"
* holder = Reference(ORG-100004108)

Instance: auth-for-14a9e800c9c8b7337e6c27b0d7936d33
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040621"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-14a9e800c9c8b7337e6c27b0d7936d33)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-5eb8039a47a953161c3d809407e075f8
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5eb8039a47a953161c3d809407e075f8)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:61
* holder = Reference(ORG-100000627)

Instance: auth-for-b3f629f916b3516763c75a379143140b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040321"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b3f629f916b3516763c75a379143140b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-b62ef02d7f298c872473be81d6a2776f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for bisoprolool, amlodipiin"
Description: "Regulated Authorization for bisoprolool, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850514"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b62ef02d7f298c872473be81d6a2776f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-17"
* holder = Reference(ORG-100000627)

Instance: auth-for-98e252160d8a05b3b34432da98ede78b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, kandesartaan"
Description: "Regulated Authorization for amlodipiin, kandesartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "959018"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-98e252160d8a05b3b34432da98ede78b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-02-13"
* holder = Reference(ORG-100000627)

Instance: auth-for-5aa7a85004ead5b3c25b02647c3d7b13
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040921"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5aa7a85004ead5b3c25b02647c3d7b13)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-a3548265bcf8910bf529bb3c5fe52082
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, ramipriil"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a3548265bcf8910bf529bb3c5fe52082)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-1c1bc64e3b67621b00457a9b5c25e531
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/569"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1c1bc64e3b67621b00457a9b5c25e531)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-10-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-3016a3bb802bbb12cee9684604486b11
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, telmisartaan"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/10/648"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3016a3bb802bbb12cee9684604486b11)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2010-10-07"
* holder = Reference(ORG-100012432)

Instance: auth-for-b5f4e393330007a97324b18215887a56
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/10/648"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b5f4e393330007a97324b18215887a56)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2010-10-07"
* holder = Reference(ORG-100012432)

Instance: auth-for-1cd4d52bdfe0cb782a5e7a5b0dfbc00a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/16/1092"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1cd4d52bdfe0cb782a5e7a5b0dfbc00a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-03-22"
* holder = Reference(ORG-100034257)

Instance: auth-for-00a9676f55edb021c8f82b87d5b52738
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007820"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-00a9676f55edb021c8f82b87d5b52738)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-cce6878d1173c2e5a657fbd6c7af3ab0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802212"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cce6878d1173c2e5a657fbd6c7af3ab0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-cf2aa8017868f4fefa99f3d5b8dfb316
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "991219"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cf2aa8017868f4fefa99f3d5b8dfb316)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100000627)

Instance: auth-for-2b0f21f21ccdaec01ec0c8fa01d0bb48
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929716"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2b0f21f21ccdaec01ec0c8fa01d0bb48)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-9df0a169966437f49f03b26709bab8da
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024421"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9df0a169966437f49f03b26709bab8da)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-c80822ec8c3a18e165e480aa4d5d06f7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/370"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c80822ec8c3a18e165e480aa4d5d06f7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-17"
* holder = Reference(ORG-100007373)

Instance: auth-for-67a139480dff8125f40f189027f4b683
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "969318"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-67a139480dff8125f40f189027f4b683)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-09-11"
* holder = Reference(ORG-100000627)

Instance: auth-for-265adbf06e4021602cc0f4aeaf17a261
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-265adbf06e4021602cc0f4aeaf17a261)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:78
* holder = Reference(ORG-100002999)

Instance: auth-for-8b106e5ac0f5025acae166f5726a78f8
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin, atorvastatiin"
Description: "Regulated Authorization for perindopriil, amlodipiin, atorvastatiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885315"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8b106e5ac0f5025acae166f5726a78f8)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-df31ead1e31acef5c5d2c545fd5f3cab
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, telmisartaan"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/10/648"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-df31ead1e31acef5c5d2c545fd5f3cab)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2010-10-07"
* holder = Reference(ORG-100012432)

Instance: auth-for-400ce3a781f8dd283dd26879dbd7bade
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/569"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-400ce3a781f8dd283dd26879dbd7bade)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-10-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-cef56e8f5244811ba5d8c6623b685120
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/16/1092"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cef56e8f5244811ba5d8c6623b685120)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-03-22"
* holder = Reference(ORG-100034257)

Instance: auth-for-a06039568a76a455e165a849723b6eeb
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "439004"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a06039568a76a455e165a849723b6eeb)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2004-03-26"
* holder = Reference(ORG-100000627)

Instance: auth-for-e3ec0d38af3d33762962f6f5a8e3948a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin, hüdroklorotiasiid"
Description: "Regulated Authorization for valsartaan, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/569"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e3ec0d38af3d33762962f6f5a8e3948a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-10-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-1d58916b8dd3a00bafe27af1e3fb67db
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/574"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1d58916b8dd3a00bafe27af1e3fb67db)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-72b0b826f032f65457e53298f4fda370
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929816"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-72b0b826f032f65457e53298f4fda370)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-16eb42ad8683f7cc606e77be16bb3a84
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/370"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-16eb42ad8683f7cc606e77be16bb3a84)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-17"
* holder = Reference(ORG-100007373)

Instance: auth-for-b766474f18c4eda952b845a9e42c80d0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, losartaan"
Description: "Regulated Authorization for amlodipiin, losartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837614"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b766474f18c4eda952b845a9e42c80d0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-6093f3b783bf08f6c470e560a3ffbf18
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/575"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6093f3b783bf08f6c470e560a3ffbf18)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-e7996c1ed086541c262eeb9fe47910a3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/575"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e7996c1ed086541c262eeb9fe47910a3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-c2fd25101e6e09f73810290b84f82748
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584308"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c2fd25101e6e09f73810290b84f82748)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-eaf37ed582d5c8bc71bb4ef0f169cf33
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/370"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-eaf37ed582d5c8bc71bb4ef0f169cf33)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-17"
* holder = Reference(ORG-100007373)

Instance: auth-for-3f21503a5cd188ccf9be98428d0804da
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/371"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3f21503a5cd188ccf9be98428d0804da)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-0a8c3cc316fe4b88649ef88e8d59107a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/372"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0a8c3cc316fe4b88649ef88e8d59107a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-515e409fcbcec32db7d621e8235dbbd4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/372"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-515e409fcbcec32db7d621e8235dbbd4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-60519618dfee43c919c39ed35a78bd3c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/574"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-60519618dfee43c919c39ed35a78bd3c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-56381f9ed6e2414526be302a64026af1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/16/1092"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-56381f9ed6e2414526be302a64026af1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-03-22"
* holder = Reference(ORG-100034257)

Instance: auth-for-2cbed639cdf7e77b747fac391470a475
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/574"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2cbed639cdf7e77b747fac391470a475)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-25b4fc8e45300bba6eff5ef9106d2efd
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, valsartaan"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/574"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-25b4fc8e45300bba6eff5ef9106d2efd)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-fbcd64d55a1ff7960f0f368ea66001c5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "441504"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-fbcd64d55a1ff7960f0f368ea66001c5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2004-03-26"
* holder = Reference(ORG-100000627)

Instance: auth-for-2cfa1681029065b8d3b986a18d159145
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/371"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2cfa1681029065b8d3b986a18d159145)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-053d71fa46984cffd297f11462a29d28
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "911616"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-053d71fa46984cffd297f11462a29d28)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-06-07"
* holder = Reference(ORG-100002040)

Instance: auth-for-e741aee8f50c989496e1e5ac8b29ce21
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid"
Description: "Regulated Authorization for amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "824513"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e741aee8f50c989496e1e5ac8b29ce21)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-b1d0fed59f6bd5f0d338293040ef2cf3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil, indapamiid"
Description: "Regulated Authorization for amlodipiin, perindopriil, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b1d0fed59f6bd5f0d338293040ef2cf3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:105
* holder = Reference(ORG-100002999)

Instance: auth-for-b4276e86dc83fab6ac5f6ee8041212de
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "527106"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b4276e86dc83fab6ac5f6ee8041212de)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2006-10-20"
* holder = Reference(ORG-100000454)

Instance: auth-for-5f96802d7b0497e6b5aa29026f16ccc3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for atorvastatiin, amlodipiin, perindopriil"
Description: "Regulated Authorization for atorvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885415"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5f96802d7b0497e6b5aa29026f16ccc3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-270e2aaac11638ede04c5cafd1c60030
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for losartaan, amlodipiin"
Description: "Regulated Authorization for losartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837814"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-270e2aaac11638ede04c5cafd1c60030)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-9b76be13d25f96c7d0b81cdfdb9d3ac5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "957217"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9b76be13d25f96c7d0b81cdfdb9d3ac5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-01-08"
* holder = Reference(ORG-100003704)

Instance: auth-for-212cd043ef53b839386c625b4918ab9d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, kandesartaan"
Description: "Regulated Authorization for amlodipiin, kandesartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915616"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-212cd043ef53b839386c625b4918ab9d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-351249d58e654827f9e59ebe4626963c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "911716"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-351249d58e654827f9e59ebe4626963c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-06-07"
* holder = Reference(ORG-100002040)

Instance: auth-for-18a11144c23574e21f39161510d12517
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1004520"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-18a11144c23574e21f39161510d12517)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-04-23"
* holder = Reference(ORG-100004108)

Instance: auth-for-98ec367fc2ab431c093c4207da8e27f6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "589308"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-98ec367fc2ab431c093c4207da8e27f6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-06-20"
* holder = Reference(ORG-100000229)

Instance: auth-for-c758d56e4501a3ee5b48ae919095b749
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023421"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c758d56e4501a3ee5b48ae919095b749)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-127820ddf691e8710504e3da06c47543
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023721"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-127820ddf691e8710504e3da06c47543)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-c37f6c31746a28e13ffc2f89183f0eb9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "537307"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c37f6c31746a28e13ffc2f89183f0eb9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100001437)

Instance: auth-for-eff5e4b813b65fd0b5c708608e84e643
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584408"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-eff5e4b813b65fd0b5c708608e84e643)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-8f1ab6bb7eff134f758bc01a7a11400f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051422"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8f1ab6bb7eff134f758bc01a7a11400f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-9d8b9f0f088c4fa91458edba48e8eceb
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "527206"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9d8b9f0f088c4fa91458edba48e8eceb)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2006-10-20"
* holder = Reference(ORG-100000454)

Instance: auth-for-e3d47a63d7d03d401fdd9419c0ffa7e1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e3d47a63d7d03d401fdd9419c0ffa7e1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-06b4952a39fc49dc5878454af1c22b0b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for atorvastatiin, amlodipiin"
Description: "Regulated Authorization for atorvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "811513"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-06b4952a39fc49dc5878454af1c22b0b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-03-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-007b8b30d1ed07c9c9fc8ed462ca5be9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007920"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-007b8b30d1ed07c9c9fc8ed462ca5be9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-a83b513233a4b315436d504b5a431a94
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, ramipriil"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785912"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a83b513233a4b315436d504b5a431a94)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-abce44b07100a3e005c95e3fdb3baba2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1004620"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-abce44b07100a3e005c95e3fdb3baba2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-04-23"
* holder = Reference(ORG-100004108)

Instance: auth-for-28d1353d30356ce33a526805a61a8d3f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, bisoprolool"
Description: "Regulated Authorization for amlodipiin, bisoprolool"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850414"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-28d1353d30356ce33a526805a61a8d3f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-15"
* holder = Reference(ORG-100000627)

Instance: auth-for-46f0c8aa3bd650910d5e1e9cabcd6c05
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802012"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-46f0c8aa3bd650910d5e1e9cabcd6c05)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-7fda85c6289c75f0d2ad509f773145c5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "606208"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7fda85c6289c75f0d2ad509f773145c5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-10-31"
* holder = Reference(ORG-100001429)

Instance: auth-for-bc73ec108516cdb2e554ae8e01c12bbb
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, indapamiid, amlodipiin"
Description: "Regulated Authorization for perindopriil, indapamiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-bc73ec108516cdb2e554ae8e01c12bbb)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:129
* holder = Reference(ORG-100002999)

Instance: auth-for-cce3df3d436666685cccca50295b0a1d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, telmisartaan"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024321"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cce3df3d436666685cccca50295b0a1d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-49410c5a96b5cd2f1358e2e0039a13fd
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, bisoprolool"
Description: "Regulated Authorization for amlodipiin, bisoprolool"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-49410c5a96b5cd2f1358e2e0039a13fd)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-15"
* holder = Reference(ORG-100000627)

Instance: auth-for-f4dadbbfdc8437dd8469c5a5eeb22d3b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "949717"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f4dadbbfdc8437dd8469c5a5eeb22d3b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-09-12"
* holder = Reference(ORG-100000627)

Instance: auth-for-8be326b6a2d2f7dc8e9a0b1ecdde5daa
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin, hüdroklorotiasiid"
Description: "Regulated Authorization for valsartaan, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "990319"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8be326b6a2d2f7dc8e9a0b1ecdde5daa)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100002040)

Instance: auth-for-75e7d65e2b8194b4150706d5827e40f6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "990519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-75e7d65e2b8194b4150706d5827e40f6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100002040)

Instance: auth-for-28cb804532c711106f195b49b04beedc
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "990219"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-28cb804532c711106f195b49b04beedc)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100002040)

Instance: auth-for-3baefb02235da077affb7060a586a6ef
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "949817"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3baefb02235da077affb7060a586a6ef)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-09-12"
* holder = Reference(ORG-100000627)

Instance: auth-for-5d169b2472129d50928a7c3e7513efd5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ramipriil, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for ramipriil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981419"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5d169b2472129d50928a7c3e7513efd5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-e7529ee95844ec2c273540d5abef2b66
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007520"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e7529ee95844ec2c273540d5abef2b66)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100003704)

Instance: auth-for-068f9138187e2397183319ac380a813a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051622"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-068f9138187e2397183319ac380a813a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-588fb3df5122e598df9909289a0315de
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017420"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-588fb3df5122e598df9909289a0315de)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-12-29"
* holder = Reference(ORG-100002999)

Instance: auth-for-e74020ba7a7045e9a3ca022fff4479fd
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, ramipriil"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785812"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e74020ba7a7045e9a3ca022fff4479fd)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-d18569adbb7a50827bc06998679d86d0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Description: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d18569adbb7a50827bc06998679d86d0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-b711418bd211ce74cee3bdddc71076a6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "882415"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b711418bd211ce74cee3bdddc71076a6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100004108)

Instance: auth-for-faa4b39968d13ba8165b496b2ebba475
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for atorvastatiin, amlodipiin"
Description: "Regulated Authorization for atorvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "845714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-faa4b39968d13ba8165b496b2ebba475)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-05-26"
* holder = Reference(ORG-100000627)

Instance: auth-for-9b59dc37d121c774366d4501f09c83d7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024221"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9b59dc37d121c774366d4501f09c83d7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-11ad222d0ac25f364d86265b5234a6ed
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, ramipriil"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-11ad222d0ac25f364d86265b5234a6ed)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:146
* holder = Reference(ORG-100002040)

Instance: auth-for-a59663efbf81a6a60d21ac51f359bde6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Description: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a59663efbf81a6a60d21ac51f359bde6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-8c59da0e27a89ee78fb22b2fd4cf0ce2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, ramipriil, amlodipiin"
Description: "Regulated Authorization for hüdroklorotiasiid, ramipriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8c59da0e27a89ee78fb22b2fd4cf0ce2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-f05a11959e96ff31465b787144cb26e6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023621"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f05a11959e96ff31465b787144cb26e6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-388a4bbc76bc7bd93f5012a225a99d01
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802312"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-388a4bbc76bc7bd93f5012a225a99d01)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-5f467326a610f24df4c1f79655358e7e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ramipriil, amlodipiin"
Description: "Regulated Authorization for ramipriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5f467326a610f24df4c1f79655358e7e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:152
* holder = Reference(ORG-100002040)

Instance: auth-for-b2d2d3244086f38209295506c37f3d7a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b2d2d3244086f38209295506c37f3d7a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:153
* holder = Reference(ORG-100002999)

Instance: auth-for-22186d9267d30078aa10e42fb71e0a79
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "567307"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-22186d9267d30078aa10e42fb71e0a79)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-12-14"
* holder = Reference(MO11501)

Instance: auth-for-a3ba23c13d9d6e610bdbdffbb09ca778
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "538707"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a3ba23c13d9d6e610bdbdffbb09ca778)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100000313)

Instance: auth-for-46abe5cdecd5f83da98c44d0fcd2c099
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, telmisartaan"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1062622"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-46abe5cdecd5f83da98c44d0fcd2c099)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-05-09"
* holder = Reference(ORG-100002999)

Instance: auth-for-9d77052c80c2ae593323615fc802e55f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ramipriil, amlodipiin"
Description: "Regulated Authorization for ramipriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9d77052c80c2ae593323615fc802e55f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:157
* holder = Reference(ORG-100002040)

Instance: auth-for-6a1189806502f55e216dfdd0bee4727d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "991119"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6a1189806502f55e216dfdd0bee4727d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100000627)

Instance: auth-for-f3aa4a484f1143ad5ff67ce0e478cf5c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for lisinopriil, amlodipiin"
Description: "Regulated Authorization for lisinopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "780112"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f3aa4a484f1143ad5ff67ce0e478cf5c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-03-01"
* holder = Reference(ORG-100000640)

Instance: auth-for-c70fe54fd6d33b760f19c13dfd878c2c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929516"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c70fe54fd6d33b760f19c13dfd878c2c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-eb67a770a9ee3dc5cb17b96bfcaedb05
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024121"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-eb67a770a9ee3dc5cb17b96bfcaedb05)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-f44976d24a835e4741c853c50e646a1e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f44976d24a835e4741c853c50e646a1e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:162
* holder = Reference(ORG-100000627)

Instance: auth-for-af348be1267291423cc55035662a5840
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "808213"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-af348be1267291423cc55035662a5840)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-03-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-48dc55ed617c44a0a2e6a56b13bf119b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833113"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-48dc55ed617c44a0a2e6a56b13bf119b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-83ec097167c802d9a2494c51504dc58f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "957417"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-83ec097167c802d9a2494c51504dc58f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-01-08"
* holder = Reference(ORG-100003704)

Instance: auth-for-34f980a7c12da71aa5f92f1eab18daf4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "954617"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-34f980a7c12da71aa5f92f1eab18daf4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-11-07"
* holder = Reference(ORG-100004108)

Instance: auth-for-5b530bc63011afbb19c29e6105b77192
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for kandesartaan, amlodipiin"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915816"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5b530bc63011afbb19c29e6105b77192)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-af58a2226a7bb27bbfd3c9897e1448ec
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "969418"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-af58a2226a7bb27bbfd3c9897e1448ec)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-09-11"
* holder = Reference(ORG-100000627)

Instance: auth-for-0ee5f36f8afc81c706a42b5387a0023d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for telmisartaan, amlodipiin"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1062522"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0ee5f36f8afc81c706a42b5387a0023d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-05-09"
* holder = Reference(ORG-100002999)

Instance: auth-for-3d8f1b0949339d791a41309aa852b94a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051722"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3d8f1b0949339d791a41309aa852b94a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-6a80df7d34a2b3298d68828963032d6b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833213"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6a80df7d34a2b3298d68828963032d6b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-8bfa8f1d8c3a452345270984e2f0d034
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "957317"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8bfa8f1d8c3a452345270984e2f0d034)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-01-08"
* holder = Reference(ORG-100003704)

Instance: auth-for-90d70636b1ce513642d96625810caf9e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, lisinopriil"
Description: "Regulated Authorization for amlodipiin, lisinopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "616709"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-90d70636b1ce513642d96625810caf9e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-02-06"
* holder = Reference(ORG-100000640)

Instance: auth-for-5b5ab6ed59e596b83f12e9c13432da7f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838814"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5b5ab6ed59e596b83f12e9c13432da7f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-9349259056595533d5e0208b7251050d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, indapamiid, amlodipiin"
Description: "Regulated Authorization for perindopriil, indapamiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9349259056595533d5e0208b7251050d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:176
* holder = Reference(ORG-100000627)

Instance: auth-for-e4e66eb770f9b7e5bce50cb0baeba199
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, rosuvastatiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, rosuvastatiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996319"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e4e66eb770f9b7e5bce50cb0baeba199)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-e4cc654eca03efb8ddc99706d49c5d4a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "991319"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e4cc654eca03efb8ddc99706d49c5d4a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100000627)

Instance: auth-for-b6b6eb359f886b600641d33c3acb531d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007620"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b6b6eb359f886b600641d33c3acb531d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100003704)

Instance: auth-for-181d1f77341ba85797d3b15314a57d95
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833313"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-181d1f77341ba85797d3b15314a57d95)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-b266c791591aaccd13a58c3bf77c89cd
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "606408"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b266c791591aaccd13a58c3bf77c89cd)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-10-31"
* holder = Reference(ORG-100001429)

Instance: auth-for-a36e6fc54f1b590dc525751e9804edb9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, olmesartaanmedoksomiil"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730311"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a36e6fc54f1b590dc525751e9804edb9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-9316836251e46376e324ea1a2e6d0d96
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, ramipriil"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785712"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9316836251e46376e324ea1a2e6d0d96)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-b918b2653c3a9b1ca27fbb3731915827
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "979719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b918b2653c3a9b1ca27fbb3731915827)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-02-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-0787020ca0af8dcad1d90da2cce4a035
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040221"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0787020ca0af8dcad1d90da2cce4a035)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-aa9b6f0d7403c46c7bca8779b1504b95
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, perindopriil"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051522"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-aa9b6f0d7403c46c7bca8779b1504b95)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-bda000a34704c31621c052c4156e4b1f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, kandesartaan"
Description: "Regulated Authorization for amlodipiin, kandesartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915716"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-bda000a34704c31621c052c4156e4b1f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-3d4395f477464cfd8826050164337d6f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil, hüdroklorotiasiid"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017520"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3d4395f477464cfd8826050164337d6f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-12-29"
* holder = Reference(ORG-100002999)

Instance: auth-for-6747a4bfd435b641b93387c863011a5d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "537207"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6747a4bfd435b641b93387c863011a5d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100001437)

Instance: auth-for-6d5da028900f96a26f7c9f06325375bf
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "902816"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6d5da028900f96a26f7c9f06325375bf)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-02-09"
* holder = Reference(ORG-100000627)

Instance: auth-for-66febb4bc6a57acc1e91c35c8b9dd7f1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, rosuvastatiin, amlodipiin"
Description: "Regulated Authorization for perindopriil, rosuvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996419"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-66febb4bc6a57acc1e91c35c8b9dd7f1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-11afb183155f9b8c8adf9a81b1bd6af6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, valsartaan"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "902916"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-11afb183155f9b8c8adf9a81b1bd6af6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-02-09"
* holder = Reference(ORG-100000627)

Instance: auth-for-bc8bc4a1d8df47334af4ef22a6835761
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "538507"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-bc8bc4a1d8df47334af4ef22a6835761)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100000313)

Instance: auth-for-c6294a4fd23138ca98050c50354cacde
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584208"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c6294a4fd23138ca98050c50354cacde)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-4f40f701d57db89cf85b48a087ad9b50
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for bisoprolool, amlodipiin, indapamiid, perindopriil"
Description: "Regulated Authorization for bisoprolool, amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4f40f701d57db89cf85b48a087ad9b50)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:195
* holder = Reference(ORG-100000964)

Instance: auth-for-893424ac2190440016f463dcdd864711
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for bisoprolool, indapamiid, amlodipiin, perindopriil"
Description: "Regulated Authorization for bisoprolool, indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-893424ac2190440016f463dcdd864711)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:196
* holder = Reference(ORG-100000964)

Instance: auth-for-48b6f97bd1a6af63c22d77e326f555dc
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for bisoprolool, indapamiid, perindopriil, amlodipiin"
Description: "Regulated Authorization for bisoprolool, indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-48b6f97bd1a6af63c22d77e326f555dc)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:197
* holder = Reference(ORG-100000964)

Instance: auth-for-5eb9a75bbbd9b52f4e32493ab201f639
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, bisoprolool"
Description: "Regulated Authorization for amlodipiin, bisoprolool"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850614"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5eb9a75bbbd9b52f4e32493ab201f639)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-15"
* holder = Reference(ORG-100000627)

Instance: auth-for-1a1967e651e3965fe8dcc42dbf2c59c0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802112"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1a1967e651e3965fe8dcc42dbf2c59c0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-eca439c8de0e2c1f38798a029c7a86cc
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "834914"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-eca439c8de0e2c1f38798a029c7a86cc)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-aa2413344919aea47e26545abb272d2e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, ramipriil"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-aa2413344919aea47e26545abb272d2e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-eaf399ed7ec71ae5059bbbd769cd45a1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin, telmisartaan"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929616"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-eaf399ed7ec71ae5059bbbd769cd45a1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-a9ee7448b2ace7e26afced7673ae186c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584108"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a9ee7448b2ace7e26afced7673ae186c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-d44d030d32eb73aa70a8d37d06ae0be4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin, indapamiid"
Description: "Regulated Authorization for perindopriil, amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833013"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d44d030d32eb73aa70a8d37d06ae0be4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-012fb5c373e2b13010dd8531088f8f9b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for amlodipiin"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "744411"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-012fb5c373e2b13010dd8531088f8f9b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-06-10"
* holder = Reference(MO193)

Instance: auth-for-7905b76d1074ee4441710f74916654ed
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for valsartaan, amlodipiin"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "903016"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7905b76d1074ee4441710f74916654ed)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-02-09"
* holder = Reference(ORG-100000627)

Instance: auth-for-0ee4e3323e22b8e8c60a7c929872c9a3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for kandesartaan, amlodipiin"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "958918"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0ee4e3323e22b8e8c60a7c929872c9a3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-02-13"
* holder = Reference(ORG-100000627)

Instance: auth-for-78b1ed9622fd52a8962a69ccc5e4a3be
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for perindopriil, amlodipiin, indapamiid"
Description: "Regulated Authorization for perindopriil, amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "832813"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-78b1ed9622fd52a8962a69ccc5e4a3be)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)
